News

Published on 2 Apr 2024 on Benzinga

Nasdaq Down Over 1%; VivoPower International Shares Spike Higher - Acorda Therapeutics...


Article preview image

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on Tuesday.

The Dow traded down 1.07% to 39,142.53 while the NASDAQ fell 1.14% to 16,209.12. The S&P 500 also fell, dropping, 0.85% to 5,199.28.

NASDAQ.GRTS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Covid-Shot Maker Goes Bankrupt After Trailing Pfizer, Moderna

(Bloomberg) -- Gritstone Bio Inc., a vaccine developer that once touted its ability to make a...

Bloomberg · via Yahoo Finance 11 Oct 2024

Penny Stock Gritstone Bio Hires Advisor To Evaluate Options, Analyst Downgrades...

On Monday, Gritstone Bio Inc. (NASDAQ:GRTS) revealed interim Phase 2 data from the ongoing Phase ...

Benzinga · via AOL 4 Oct 2024

Gritstone bio, Inc. (NASDAQ:GRTS) Q1 2024 Earnings Call Transcript

Gritstone bio, Inc. (NASDAQ:GRTS) Q1 2024 Earnings Call Transcript May 9, 2024 Gritstone bio, Inc...

Insider Monkey via Yahoo Finance 8 May 2024

Gritstone bio Inc. (GRTS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The market expects Gritstone bio Inc. (GRTS) to deliver flat earnings compared to the year-ago qu...

Zacks via Yahoo Finance 2 May 2024

Gritstone (GRTS) Plummets 58% in a Week: Here's Why

Gritstone Bio GRTS is a clinical-stage biotechnology company focused on developing vaccines targe...

Zacks via Yahoo Finance 4 Apr 2024

Nasdaq Down Over 1%; VivoPower International Shares Spike Higher - Acorda Therapeutics...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on ...

Benzinga 2 Apr 2024

What's Going On With Small Cap Cancer Vaccine Focused Gritstone Bio Stock On Tuesday?

Tuesday, Gritstone Bio Inc (NASDAQ:GRTS) released preliminary data from the ongoing, signal-seeki...

Benzinga via Yahoo Finance 2 Apr 2024

Gritstone Bio launches public stock and warrant offering

Gritstone Bio, Inc. (NASDAQ:GRTS), a clinical-stage biotechnology company, has announced the...

Investing.com 1 Apr 2024

Do Options Traders Know Something About Gritstone bio (GRTS) Stock We Don't?

Investors in Gritstone bio, Inc. GRTS need to pay close attention to the stock based on moves in ...

Zacks via Yahoo Finance 18 Mar 2024

Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates

Gritstone bio Inc. (GRTS) came out with a quarterly loss of $0.26 per share versus the Zacks Cons...

Zacks via Yahoo Finance 5 Mar 2024